lipidcontain
membran
envelop
nucleocapsid
bvdv
account
low
buoyant
densiti
virion
easili
broken
organ
solvent
ether
chloroform
infect
thu
readili
inactiv
hermodsson
dinter
dinter
consider
decreas
infect
achiev
treatment
bvdv
suspens
trypsin
mg
ml
min
effect
ph
rang
reveal
rel
stabil
outsid
rang
infect
decreas
rapidli
hafez
liess
lack
inform
inactiv
bvdv
variou
agent
disinfect
necessit
comparison
within
genu
pestiviru
effect
physic
chemic
treatment
hog
cholera
viru
hcv
might
also
appli
bvdv
liess
bvdv
appli
natur
rout
oral
intranas
induc
antibodi
upon
multipl
natur
host
bovin
small
rumin
pig
immun
sera
neutral
bvdv
shown
experi
calv
baker
et
al
host
system
eg
cell
cultur
bovin
origin
noic
schipper
gillespi
et
al
neutral
antibodi
specif
bind
surfac
antigen
bvd
virion
antibodi
develop
also
intern
antigen
viral
particl
demonstr
serolog
method
howev
method
eg
agargel
precipit
less
suitabl
identif
bvdv
strain
differenti
close
relat
hcv
darbyshir
work
monoclon
antibodi
lead
identif
viral
protein
typeor
strainspecif
within
nonarbo
togaviru
group
crossreact
occur
rubella
viru
equin
arter
viru
lactic
dehydrogenas
viru
pestivirus
horzinek
serolog
relat
virus
hcv
bvdv
relationship
express
common
solubl
antigen
detect
exampl
agar
doubl
diffus
test
gutekunst
malmquist
also
presenc
neutral
antibodi
bvdv
pig
sera
snowdon
french
separ
speci
due
subgroupspecif
antigen
locat
membran
virion
even
neutral
would
differenti
speci
unless
homolog
heterolog
titer
compar
quantit
differ
basi
exist
either
common
typespecif
antigen
membran
ii
variabl
typespecif
antigen
would
also
explain
antigen
variat
amongst
strain
bvdv
latter
well
establish
mainli
neutral
use
immun
sera
prepar
differ
bvdv
strain
calv
gillespi
et
al
castrucci
et
al
order
exclud
individu
differ
group
pig
inocul
low
virul
strain
hcv
mean
antibodi
titer
plot
heterolog
hcv
well
bvdv
strain
distinct
profil
obtain
reflect
antigen
variat
bvdv
relationship
amongst
strain
test
fig
host
rang
bvdv
seem
restrict
domest
wild
rumin
pig
speci
infect
field
judg
detect
antibodi
specif
bvdv
report
mani
investig
adapt
bvdv
serial
passag
rabbit
report
speci
must
regard
natur
host
baker
et
al
reservoir
host
known
except
persist
infect
cattl
calv
infect
utero
transplacent
viru
transmiss
malmquist
vector
amongst
invertebr
report
howev
resembl
bvdv
arbo
togavirus
demand
attent
lack
antibodi
absenc
clinic
symptom
indic
bvdv
transmit
man
justifi
conclus
consid
wide
distribut
bvdv
cattl
popul
bvdv
widespread
north
america
europ
global
distribut
therefor
astonish
appar
countri
bvdv
occur
judg
absenc
neutral
antibodi
cattl
popul
report
china
cattl
kept
small
hold
j
chen
person
commun
serolog
survey
reveal
high
preval
neutral
antibodi
cattl
popul
mani
countri
intens
cattl
industri
frequent
movement
anim
within
countri
well
import
favor
spread
bvdv
incid
bvdv
infect
clinic
diseas
lethal
cours
confirm
laboratori
investig
seem
low
compar
figur
obtain
serosurvey
howev
without
intens
record
notif
diseas
detail
inform
diagnost
method
econom
consequ
bvd
hardli
estim
spread
bvdv
pattern
speed
properli
determin
case
occur
unnot
infect
inappar
field
condit
bvdv
enter
host
organ
oral
rout
depend
circumst
nasal
rout
tonsil
lymphoid
tissu
line
oropharynx
find
cell
primari
multipl
particularli
epitheli
cell
crypt
tonsil
viral
antigen
demonstr
bvdv
virusinfect
cell
debri
may
taken
phagocyt
cell
transport
drain
lymphoid
tissu
bielefeldt
ohmann
viru
could
detect
blood
day
oral
nasal
bvdv
inocul
calv
mill
luginbuhl
rohd
liess
infect
mainli
found
leukocyt
bufifi
coat
day
onset
demonstr
antibodi
format
suggest
viru
associ
leukocyt
way
access
neutral
antibodi
blood
plasma
infect
disappear
soon
neutral
antibodi
could
detect
spread
viru
organ
site
primari
multipl
occur
viremia
eventu
ceas
infect
organ
seem
elimin
viru
bvdv
excret
via
secret
excret
larg
quantiti
viru
found
saliva
nasal
discharg
lesser
extent
urin
fece
absenc
diarrhea
rare
experiment
case
bvdv
infect
run
seriou
even
fatal
cours
baker
et
al
allow
investig
organ
manifest
viremia
less
sever
clinic
symptom
patholog
chang
relat
term
introduc
condit
first
describ
bovin
viru
diarrhea
olafson
et
al
olafson
rickard
mucos
diseas
ramsey
chiver
epizootiolog
impact
viral
latenc
persist
great
interest
bvdv
ack
properti
would
allow
genom
becom
integr
cell
genom
persist
bvdv
infect
well
establish
play
import
role
epizootiolog
also
pathogenesi
diseas
diagnost
procedur
well
control
strategi
includ
immun
prophylaxi
take
persist
account
recoveri
bvdv
lung
bronchial
lymphnod
day
pi
intranas
viru
applic
atom
report
mill
luginbuhl
appear
insuffici
claim
viral
persist
present
context
meant
bvdv
persist
lifelong
eg
bufifi
coat
cell
without
caus
clinic
sign
bvd
state
attribut
specif
immun
toler
liess
coria
mcclurkin
specif
unrespons
humor
immun
system
bvdv
highli
contamin
milieu
suggest
holl
johnson
muscoplat
investig
immunolog
abnorm
calv
chronic
bvd
syndrom
offer
two
theori
unrespons
lymphocyt
phytohemagglutinin
stimul
well
defici
humor
respons
immunosuppress
effect
diseas
ii
immunolog
unrespons
factor
caus
diseas
neither
theori
could
verifi
avail
data
shope
et
al
studi
role
cellular
immun
passiv
antibodi
protect
neonat
calv
primari
bvdv
infect
use
administr
corticosteroid
day
observ
intratrach
infect
calv
without
antibodi
die
other
high
level
passiv
transfer
antibodi
otherwis
similar
condit
contrast
administr
mgkgday
start
day
oral
nasal
inocul
field
strain
bvdv
result
mild
clinic
symptom
rohd
liess
shope
et
al
conclud
sever
fatal
viremia
immunosuppress
calv
appar
result
extens
dissemin
bvd
viru
target
organ
particularli
lymphoid
tissu
bvd
viral
persist
consid
precondit
develop
sever
clinic
diseas
total
protein
immunoglobulin
serum
persist
infect
anim
becam
interest
fact
immunoglobulin
g
x
g
could
detect
precolostr
sera
eleven
persist
bvdinfect
calv
attribut
insensit
test
complex
ig
bvdv
sinc
viru
isol
sera
coria
et
al
use
sensit
test
procedur
coulibali
abl
demonstr
significantli
decreas
igg
concentr
sera
healthi
persist
bvdinfect
cattl
rang
month
year
age
confirm
result
obtain
steck
et
al
cattl
fatal
affect
bvdmd
syndrom
deplet
circul
lymphocyt
latter
particular
bolin
et
al
well
depress
respons
mitogen
stimul
lymphocyt
reflect
influenc
bvdv
immun
system
whether
immunosuppress
play
role
fatal
outcom
bvdv
infect
still
need
shown
corticosteroid
treatment
may
suppress
effect
local
antibodi
format
appear
somewhat
unlik
neutral
antibodi
control
viremia
suggest
shope
et
al
sinc
bvdv
infect
intim
associ
leukocyt
peripher
blood
persist
day
pi
mill
luginbuhl
presenc
neutral
antibodi
viru
could
recov
least
day
rohd
liess
factor
taken
account
explain
pathogenet
mechan
bvdv
infect
run
sever
cours
fatal
infect
cattl
frequent
produc
detect
antibodi
bvdv
presum
phenomenon
due
immunolog
toler
consequ
antigen
experi
birth
malmquist
although
exposur
lowpassag
bvdv
neonat
calv
die
liess
lambert
et
al
caus
fatal
bvdv
infect
role
immunolog
toler
remain
obscur
nevertheless
case
fatal
bvdv
infect
expect
among
seroneg
anim
herd
high
percentag
heifer
cow
seroposit
bvdv
hand
select
seroneg
anim
highli
contamin
environ
offer
chanc
find
persist
infect
anim
die
sooner
later
liess
et
al
hypothesi
result
detect
persist
bvdvinfect
calv
heifer
young
bull
pregnant
cow
follow
longer
period
time
mcclurkin
et
al
liess
et
al
persist
infect
anim
probabl
expos
bvdv
intrauterin
life
germann
romvari
report
bvdv
infect
newborn
dayold
calv
outcom
transplacent
viru
transfer
bovin
fetu
depend
gestat
stage
seroneg
dam
earliest
date
matern
infect
neutral
antibodi
format
fetu
stimul
appear
rang
scott
et
al
day
gestat
kendrick
length
period
transplacent
transfer
unknown
yet
probabl
rang
day
onward
transplacent
infect
also
interfer
fertil
princip
manifest
advers
effect
bvdv
infect
grahn
et
al
result
investig
ontogenesi
bovin
immun
system
schultz
b
conclud
bovin
fetu
develop
immunolog
respons
bvdv
antigen
day
gestat
attempt
isol
bvdv
fetus
produc
neutral
antibodi
promis
success
kahr
done
et
al
orban
et
al
establish
persist
viremia
shown
lifelong
detect
bvdv
buffi
coat
cell
coria
mcclurkin
transplacent
transfer
bvdv
within
first
trimest
gestat
import
recent
could
shown
seroneg
cow
day
pregnant
vaccin
commerci
bvd
modifi
live
viru
vaccin
deliv
virem
calv
persist
virem
month
anim
show
growth
retard
runt
remain
healthi
year
fig
time
shed
vaccin
viru
variou
rout
none
persist
infect
calv
show
precolostr
neutral
antibodi
infect
viru
find
live
modifi
bvdv
vaccin
bvdvcontamin
vaccin
lohr
et
al
establish
persist
infect
must
also
consid
light
report
detect
bvdv
commerci
fetal
calf
sera
use
cell
cultur
kniazeff
et
al
malmquist
king
hark
nuttal
et
al
liess
et
al
unpublish
data
experiment
cattl
persist
noncytopathogen
nc
bvdv
viremia
may
develop
md
infect
cytopathogen
c
strain
bvdv
brownli
et
al
bolin
et
al
c
md
may
also
consequ
mutat
persist
infect
ncbvdv
cbvdv
brownli
et
al
howard
et
al
latter
hypothesi
support
result
crossneutr
test
cand
ncstrain
pair
strain
deriv
certain
case
md
indistinguish
differ
pair
strain
isol
case
md
larsson
studi
activ
mononuclear
cell
mnc
peripher
blood
md
persist
infect
bvdv
cattl
md
commonli
show
normal
mnc
count
alter
composit
subpopul
mean
proport
igbear
cell
b
cell
increas
cell
neither
ig
attach
cell
marker
helix
pomatia
hemagglutinin
hp
decreas
proport
mononuclear
phagocyt
phagocyt
capac
vari
within
normal
rang
persist
infect
healthi
cattl
show
alter
composit
mnc
seen
cattl
md
md
subclin
persist
infect
prolif
respons
mnc
mitogen
suppress
partli
due
increas
suppressor
activ
cell
receptor
fc
part
igg
fc
cell
increas
number
cell
almost
te
fci
cell
attach
hp
indic
cell
suppressor
activ
subset
cell
olafson
cowork
olafson
et
al
olafson
rickard
describ
bovin
viru
diarrhea
febril
diseas
character
leukopenia
saliv
nasal
discharg
profus
scour
cough
depress
anorexia
develop
ulcer
mild
case
clinic
symptom
detect
call
sleeper
subclin
case
anim
observ
abort
day
month
later
transmiss
experi
feed
anim
fecal
materi
subcutan
inject
blood
febril
anim
mode
inocul
result
variabl
symptom
cours
diseas
compar
observ
natur
infect
anim
occasion
experiment
anim
die
infect
bvdv
first
report
olafson
cowork
describ
clinic
lesion
later
confirm
investig
unfortun
led
introduct
new
term
infect
notabl
mucos
diseas
ramsey
chiver
contribut
confus
aros
clinic
similar
etiolog
differ
diseas
situat
becam
even
complic
group
syndrom
later
recogn
etiolog
differ
bvd
refer
mucos
diseas
cattl
fmd
rinderpest
ibr
etc
consequ
name
like
mucos
diseas
complex
malmquist
mucos
diseas
ramsey
huck
avoid
mark
resembl
mucos
diseas
rinderpest
ramsey
consid
possibl
incorrect
diagnosi
mucos
diseas
could
made
earli
stage
outbreak
rinderpest
potenti
seriou
consequ
earlier
walker
olafson
shown
cattl
reconvalesc
bvd
immun
rinderpest
detect
antibodi
rinderpest
viru
accept
bvd
md
repres
two
differ
clinic
pictur
common
etiolog
agent
gillespi
et
al
md
consid
late
onset
immunolog
mediat
condit
occur
cattl
persist
infect
bvdv
liess
roeder
display
criteria
slow
viru
infect
porter
liess
et
al
apart
bvd
initi
describ
acut
gastroenter
sever
diarrhea
olafson
et
al
md
report
occur
low
morbid
high
lethal
third
cours
identifi
chronic
infect
sever
week
durat
calv
year
age
chronic
syndrom
character
interdigit
hyperkeratosi
ulcer
diarrhea
dehydr
weak
failur
thrive
malmquist
mention
calv
md
persist
viremia
fail
develop
neutral
antibodi
extend
period
longest
approxim
month
anim
remain
unthrifti
slowgain
poordoer
becam
sick
frequent
sick
time
coria
mcclurkin
relat
unthrifti
congenit
infect
bvdv
calv
surviv
month
usual
persist
infect
chronic
ill
report
compar
detail
chronic
outbreak
prolong
cours
sever
month
howev
mainli
affect
adult
anim
huck
final
mild
outbreak
herd
character
subclin
transient
symptom
report
huck
mild
cours
individu
anim
known
sinc
first
report
olafson
et
al
case
without
promin
symptom
sleeper
subclin
case
agreement
transmiss
experi
calv
gener
reproduc
complet
clinic
pictur
diseas
malmquist
case
calv
die
enter
within
h
birth
must
seen
light
present
knowledg
virus
caus
neonat
diarrhea
eg
rotavirus
coronavirus
rare
event
bvdv
infect
except
establish
utero
literatur
obviou
transmiss
experi
far
fail
fulfil
second
henlekoch
postul
requir
viru
materi
use
inocul
contamin
virus
liess
usual
bvdv
serial
passag
bovin
cell
cultur
serv
inoculum
report
select
procedur
eg
limit
dilut
plaqu
isol
lack
point
need
consider
view
frequent
occurr
ncbvdv
bovin
materi
primari
bovin
cell
cultur
fetal
calf
sera
use
propag
bvdv
isol
must
check
use
eg
fluoresc
antibodi
interfer
test
macroscop
lesion
first
describ
olafson
cowork
olafson
et
al
olafson
rickard
vari
consider
accord
cours
infect
sever
acut
mild
chronic
sever
case
extens
ulcer
diffus
necrosi
mucou
membran
upper
digest
respiratori
tract
occur
occasion
calv
die
without
develop
ulcer
present
stomach
mucosa
redden
petechia
hemorrhag
omasum
small
intestin
cecum
appear
variabl
hemorrhag
subcutan
tissu
epicardium
vagin
mucosa
ramsey
describ
variat
gross
lesion
note
one
affect
herd
socal
mucos
diseas
eros
ulcer
cystic
lesion
confin
epithelia
mucosa
alimentari
canal
hyperemia
hemorrhag
common
find
oral
caviti
necrosi
epithelium
produc
lesion
irregular
outlin
loss
necrot
surfac
epithelium
left
eros
ulcer
hyperem
base
necrosi
eros
appear
vari
degre
locat
eg
esophagu
forestomach
abomasum
sever
catarrh
enter
notic
mainli
jejunum
inflamm
part
intestin
wsa
common
histopatholog
examin
reveal
thrombosi
vessel
submucos
area
ulcer
small
arteriol
abomasum
gut
describ
contain
hyalin
emboli
lesion
circulatori
system
consist
increas
capillari
permeabl
diffus
periarter
shown
circumferenti
necrosi
leukocyt
infiltr
lymph
node
mark
decreas
mononuclear
cell
expos
basal
tissu
lymphoid
organ
mark
decreas
lymphocyt
also
found
spleen
indic
lymphoid
exhaust
carlson
et
al
tyler
ramsey
liver
pancrea
salivari
gland
gener
appear
normal
ramsey
respiratori
system
diffus
lesion
consist
petechi
ecchymot
hemorrhag
evid
inflamm
subviscer
pleura
tracheal
mucosa
howev
trachea
lung
appear
normal
anim
ramsey
edema
larynx
trachea
occur
case
carlson
et
al
epitheli
hyalin
droplet
renal
glomeruli
tubul
common
find
ramsey
gross
microscop
alter
central
nervou
system
found
ramsey
enceph
report
other
carlson
et
al
khater
et
al
lesion
skin
consist
focal
prolif
dermat
ramsey
note
protract
case
ramsey
accord
carlson
et
al
gross
microscop
chang
promin
anim
subacut
chronic
recov
case
least
promin
earli
experiment
case
md
patholog
chang
describ
much
sever
bvd
consist
mainli
eros
ulcer
destruct
lymphat
tissu
alimentari
tract
similar
bvd
distribut
charact
compar
studi
patholog
respons
select
isol
case
bvd
md
tyler
ramsey
conclud
imposs
clarifi
variabl
syndrom
seen
field
experiment
syndrom
alway
mild
resembl
viru
diarrhea
rather
md
respiratori
tract
portal
entri
bvdv
bielefeldt
ohmann
conclud
bvdv
initi
replic
epithelia
tonsil
bronchioli
viru
infect
cell
transport
drain
tissu
phagocyt
cell
involv
blood
vessel
accompani
degen
chang
howev
accord
bielefeldt
ohmann
bvdvantigencontain
migrat
mononuclear
cell
relat
degen
chang
vicin
cutlip
et
al
investig
clinic
healthi
cattl
persist
infect
bvdv
found
viral
antigen
endotheli
cell
direct
blood
vessel
brain
cuf
mononuclear
cell
begin
lesion
submucosa
show
degen
chang
basal
layer
without
surfac
necrosi
although
often
necrosi
extend
deeper
layer
epithelium
degen
process
character
vacuol
cytoplasm
mainli
stratum
spinosum
initi
disappear
intercellular
bridg
cell
enlarg
due
increas
cytoplasm
volum
pycnosi
nuclei
format
small
vesicl
lead
detach
surfac
epithelium
leav
eros
ramsey
hansen
et
al
accord
seibold
circulatori
failur
lamina
propria
gastrointestin
mucosa
result
hyperemia
hemorrhag
petechia
ecchymos
bvdv
known
cross
placenta
give
rise
abort
antibodi
format
fetu
romvari
kahr
patholog
chang
initi
experiment
intrauterin
infect
time
fetal
develop
intraven
inocul
eleven
cow
day
pregnant
three
neonat
calv
show
sign
diseas
newborn
cow
inocul
fetu
day
age
atax
blind
low
presuckl
titer
neutral
antibodi
bvdv
compar
calv
two
calv
weak
buccal
erythema
eros
report
major
calv
appear
normal
ward
et
al
bvdv
appar
mild
patholog
effect
older
fetus
sever
reaction
expect
occur
embryo
young
fetus
natur
infect
age
viru
kill
conceptu
nine
cow
inocul
bvdv
first
trimest
pregnanc
deliv
three
normal
calv
one
calf
partial
alopecia
one
mummifi
fetu
three
abort
one
stillbirth
kendrick
anoth
studi
fetu
amniot
vesicl
placentom
cow
day
gestat
inocul
bvdv
irrespect
presenc
neutral
antibodi
sever
lesion
decreas
age
fetus
increas
casaro
et
al
congenit
anomali
consist
inflamm
moder
necrosi
bronchial
epithelium
nonsuppur
dermat
necrosi
basal
cell
epidermi
nonsuppur
mening
destruct
extern
granular
layer
cerebellum
lesion
occur
period
organogenesi
lesion
result
matern
infect
first
trimest
repres
mainli
malform
degener
cerebellum
eye
cataract
retin
degener
later
fetus
acquir
abil
react
inflamm
scott
et
al
inocul
cattl
gestat
day
later
field
strain
bvdv
result
intrauterin
death
without
abort
mummif
growth
retard
without
malform
andor
dysmyelin
central
nervou
system
done
et
al
bielefeldt
ohmann
trautwein
et
al
bvdv
usual
produc
lifelong
immun
kahr
immunolog
basi
phenomenon
unknown
state
presenc
neutral
antibodi
blood
serum
reflect
immun
robson
et
al
immun
compet
cattl
activ
immun
follow
field
infect
chapter
refer
p
applic
bvd
live
viral
vaccin
consid
immun
beyond
life
expect
dairi
cow
kahr
et
al
sinc
transplacent
transmiss
bvdv
occur
frequent
review
immun
reaction
bvdv
must
includ
fetu
stage
bovin
fetu
acquir
immun
compet
bvdv
estim
casaro
et
al
around
day
gestat
brown
et
al
studi
immun
reaction
fetus
gestat
age
day
quantit
serum
immunoglobulin
day
intraven
inocul
serolog
neg
pregnant
heifer
igm
appear
first
fetu
day
inocul
dam
follow
igg
igg
bvdvspecif
antibodi
detect
fetu
day
matern
inocul
assum
immunoglobulin
product
occur
respons
infect
fetu
sinc
matern
immunoglobulin
normal
cross
placenta
recent
bielefeldt
ohmann
et
al
inocul
four
fetus
bvdv
utero
three
week
later
caesarian
section
test
immunoglobulin
neutral
antibodi
infect
bvdv
strain
anoth
laboratori
strain
fetus
respond
mark
igm
igg
product
immunoglobulin
absent
abbattoir
fetus
age
appear
iga
relat
develop
peyer
patch
presenc
plasma
cell
intestin
submucosa
major
sourc
iga
rumin
two
fetus
show
neutral
antibodi
homolog
strain
none
heterolog
strain
bvdv
antigen
detect
fetal
tissu
two
fetus
repres
youngest
individu
far
report
mount
specif
respons
experiment
bvdv
infect
within
week
investig
report
day
casaro
et
al
schultz
b
outlin
viral
persist
play
major
role
bvd
may
result
specif
immun
toler
appar
relat
develop
chronic
bvd
md
steck
et
al
studi
cattl
fatal
infect
bvdv
cattl
found
signific
reduct
igg
level
immunoglobulin
normal
observ
made
clinic
healthi
cattl
persist
infect
bvdv
coulibali
accord
steck
et
al
sera
devoid
bvdv
antibodi
neutral
virus
extent
degre
sera
healthi
cattl
react
rotaviru
bovin
parvoviru
lack
igg
observ
nansen
high
frequenc
among
anim
affect
pyogen
bacteria
believ
associ
reduc
resist
infect
immunecompet
suscept
cattl
respond
bvdv
product
usual
high
titer
neutral
antibodi
highli
specif
antigen
variant
strain
use
convincingli
shown
steck
et
al
vaccin
experi
use
virem
anim
seroneg
homolog
isol
well
vaccin
strain
vaccin
remain
test
homolog
bvdv
strain
develop
high
neutral
titer
vaccin
strain
recent
find
confirm
test
persist
virem
cattl
field
howev
immunecompet
anim
infect
one
strain
obvious
immun
heterolog
strain
also
develop
neutral
antibodi
strain
variant
strain
differenti
measur
neutral
antibodi
titer
show
higher
valu
homolog
heterolog
strain
strain
recogn
specif
immunecompet
cattl
pig
shown
fig
malmquist
castrucci
et
al
liess
et
al
summari
bvdv
strain
induc
immun
toler
recogn
immunolog
even
fetal
organ
acquir
immun
compet
strain
recogn
result
strain
specif
antibodi
format
calv
born
infect
dam
take
matern
bvdv
antibodi
ingest
colostrum
within
h
calv
natur
infect
herd
possess
antibodi
serum
titer
declin
exponenti
undetect
level
day
depend
level
initi
titer
malmquist
kendrick
franti
high
medium
low
initi
valu
kendrick
franti
expect
titer
approach
zero
approxim
day
respect
halflif
neutral
antibodi
sera
colostrumf
calv
calcul
day
landeliu
cmi
respons
studi
investig
although
signific
small
lymphocyt
deplet
defens
mechan
relat
secondari
bacteri
viral
infect
emphas
malmquist
studi
hamper
imposs
consist
produc
clinic
case
md
therefor
steck
et
al
select
cattl
fatal
infect
bvdv
studi
vitro
respons
lymphocyt
stimul
phytohemagglutinin
concanavalin
differ
sick
anim
control
seen
except
sera
anim
later
stage
fatal
bvdmd
show
suppress
effect
stimul
johnson
muscoplat
use
lymphocyt
calv
chronic
bvdv
infect
report
inhibit
mitogen
effect
phytohemagglutinin
compar
lymphocyt
respons
healthi
control
calv
vitro
studi
stimulatori
effect
pokewe
mitogen
bovin
splenic
lymphoid
cell
infect
bvdv
support
hypothesi
bvdv
alter
bcell
respons
plasma
cell
develop
subsequ
synthesi
igg
igm
atlurn
et
al
howev
observ
explain
develop
sever
fatal
cours
bvdv
infect
decreas
polymorphonuclear
leukocyt
impair
function
may
part
explain
increas
suscept
cattl
secondari
bacteri
infect
bvdv
infect
roth
et
al
remain
open
whether
inhibit
vitro
respons
lymphocyt
mitogen
decreas
bcell
function
connect
impair
igg
igm
synthesi
effect
caus
fatal
late
onset
form
bvdv
infect
consid
variou
diseas
pictur
bvd
one
remind
immun
pathogenet
phenomena
especi
immunolog
toler
persist
infect
anim
particular
antigen
variant
bvdv
calv
failur
make
antibodi
attribut
coria
mcclurkin
immun
toler
immun
paralysi
immun
suppress
unrespons
later
cutlip
et
al
describ
microscop
lesion
kidney
persist
infect
cattl
bvdv
antigen
mesangi
endotheli
cell
glomeruli
suggest
immunemedi
reaction
deposit
small
amount
antibodi
incomplet
immun
toler
complex
viral
antigen
renal
glomeruli
along
basement
membran
similar
situat
lymphocyt
choriomening
mice
oldston
dixon
immun
complex
inde
demonstr
renal
glomeruli
persist
bvdvinfect
cattl
exactli
locat
report
other
prager
liess
sera
infect
seroposit
cattl
unequivoc
discrimin
infect
nc
strain
infect
cbvdv
biotyp
radioimmun
precipit
cell
lysat
viral
protein
k
present
lysat
cell
infect
cbvdv
strain
share
epitop
precursor
protein
k
present
cell
infect
c
nc
strain
doni
dubovi
absenc
low
preval
protein
k
cell
infect
nc
strain
ie
absenc
k
protein
process
describ
akkina
confirm
pocock
et
al
other
clinic
case
suspect
bvdv
infect
must
confirm
laboratori
test
also
true
specimen
anim
submit
post
mortem
examin
even
without
anamnest
suspicion
infect
addit
may
necessari
perform
test
preval
antibodi
bvdv
cattl
popul
detect
antibodi
mean
viru
neutral
frequent
use
test
variabl
serumconst
viru
procedur
routin
employ
calcul
neutral
titer
initi
serum
dilut
use
posit
titer
aris
soon
infect
reach
valu
far
beyond
initi
dilut
usual
depend
strain
amount
bvdv
use
neutral
may
measur
presenc
c
nc
strain
bvdv
latter
case
fluoresc
antibodi
ferneliu
peroxidaselink
antibodi
holm
jensen
may
use
microtit
system
use
highli
cytopathogen
strain
eg
oregon
cytopath
effect
may
increas
seed
cultur
cell
togeth
virusserum
mixtur
frey
liess
instanc
determinatin
neutral
index
reduct
plaqu
number
use
antibodi
quantit
gillespi
et
al
hafez
liess
detect
anim
persist
infect
bvdv
neg
neutral
titer
give
indic
malmquist
use
identifi
carrier
prevent
loss
might
occur
among
anim
sooner
later
holl
seroneg
persist
infect
cattl
may
appear
healthi
bvdv
isol
blood
coria
mcclurkin
liess
et
al
vaccin
may
develop
neutral
antibodi
bvd
vaccin
strain
vaccin
affect
state
viral
persist
circul
persist
viru
even
plasma
found
persist
bvdv
infect
cattl
may
develop
sign
chronic
diseas
case
viru
cultur
buffi
coat
peripher
blood
even
presenc
demonstr
neutral
antibodi
coria
mcclurkin
antibodi
may
transfer
colostrum
activ
produc
persist
infect
anim
heterolog
bvdv
eg
vaccin
viru
steck
et
al
viru
isol
blood
sampl
suitabl
contain
heparin
edta
prevent
coagul
facilit
separ
collect
leukocyt
fraction
lowspe
centrifug
wash
resuspens
buffi
coat
leukocyt
inocul
cultur
suscept
bovin
cell
incub
day
cellcultur
fluid
collect
passag
prefer
establish
monolay
cell
cultur
examin
presenc
bvdv
fluoresc
antibodi
enzymelink
antibodi
interfer
especi
concern
nc
strain
cbvdv
strain
detect
instanc
nc
strain
frequent
isol
persist
infect
healthi
anim
coria
mcclurkin
even
chronic
affect
cattl
chronic
infect
may
impress
begin
becom
appar
anim
age
therefor
search
persist
infect
viru
excret
anim
amongst
show
clinic
sign
utmost
import
characterist
found
among
seroneg
anim
older
month
young
anim
may
virem
spite
possess
matern
antibodi
case
acut
diseas
blood
sampl
may
collect
sick
anim
viru
isol
well
determin
neutral
antibodi
especi
valuabl
anim
age
matern
antibodi
still
present
month
antibodi
may
interfer
diagnost
procedur
anim
allow
die
homogen
tissu
viru
isol
usual
treatment
antibiot
may
result
neutral
bvdv
incub
antibodi
present
lymph
cell
contain
bvdv
antigen
long
period
presenc
antibodi
consid
ferneliu
lambert
evid
lowgrad
carrier
state
result
ferneliu
lambert
found
support
bielefeldt
ohmann
et
al
abl
isol
bvdv
fetus
inocul
month
age
examin
week
later
instead
viral
antigen
demonstr
section
sever
fetal
organ
primarili
lymphoid
tissu
bielefeldt
ohmann
et
al
hyperimmun
serum
experi
rais
pig
repeat
intraven
inject
bvdv
bvdv
antigen
detect
fluoresceinor
enzymelink
antibodi
wide
use
laboratori
diagnost
procedur
tissu
section
variou
organ
prefer
tonsil
paroti
spleen
lymph
node
mucosa
gastrointestin
tract
suitabl
main
limit
method
come
presenc
matern
antibodi
autolysi
field
materi
inadequ
transport
condit
moreov
specif
conjug
import
usual
prepar
bovin
serum
may
contain
antibodi
mani
virus
hightit
bvdv
antiserum
rais
pig
take
advantag
anamnest
respons
challeng
hcv
overbi
liess
et
al
hyera
et
al
fact
fetal
infect
bvdv
occur
extent
higher
commonli
expect
diagnost
procedur
must
appli
fetus
case
abort
stillbirth
perinat
death
support
find
amongst
abort
fetus
denmark
posit
bvdv
viru
isol
orand
specif
antibodi
detect
periton
fluid
l
ronsholt
person
commun
sinc
blood
sampl
incident
obtain
case
laboratori
diagnosi
base
detect
viral
antigen
immunoperoxidas
techniqu
viru
isol
primari
calf
kidney
cell
bovin
cell
line
outlin
carbrey
periton
fluid
fetus
young
calv
blood
sampl
avail
includ
diagnost
procedur
sinc
mani
case
nc
strain
bvdv
involv
proper
techniqu
isol
identif
utmost
import
includ
three
four
subchapt
refer
p
passag
whenev
viru
found
one
passag
subsequ
inocul
coverslip
cell
cultur
interfer
test
consid
diagnosi
congenit
infect
calv
fed
colostrum
matern
antibodi
could
interfer
diagnost
procedur
antibodi
found
exampl
periton
fluid
abort
fetus
older
day
gestat
age
probabl
activ
produc
bielefeldt
ohmann
et
al
detect
precolostr
blood
sampl
newborn
calv
past
prophylaxi
bvdv
infect
subject
mani
controversi
public
said
seem
plausibl
transplacent
transmiss
bvdv
prevent
immun
cattl
pregnanc
duffel
et
al
liess
first
vaccin
bvd
consist
attenu
viru
strain
oregon
passag
produc
ill
calv
conclud
safe
efficaci
coggin
et
al
extens
use
vaccin
postvaccin
condit
observ
characterist
similar
md
thought
due
failur
immun
mechan
anim
peter
et
al
postvaccin
complic
discuss
usa
year
administr
attenu
bvdv
consid
harm
benefici
particularli
anim
carrier
state
gutekunst
apart
possibl
postvaccin
condit
bittl
disagr
notic
efficaci
live
attenu
bvdv
vaccin
durat
immun
estim
longlast
lifelong
bvdv
field
infect
provid
vaccin
administ
time
colostr
immun
interfer
immun
kahr
et
al
problem
safeti
result
attempt
develop
inactiv
vaccin
order
prevent
effect
follow
passag
bvdv
via
placenta
fetu
abort
cerebellar
hypoplasia
ocular
lesion
stillbirth
weak
diarrhea
suspect
occur
natur
bvdv
infect
first
half
gestat
ward
mcclurkin
et
al
report
describ
resist
acriflavin
marker
attenu
bvdv
strain
acr
rockborn
et
al
call
studi
ascertain
whether
acr
strain
suffici
attenu
immunogen
use
vaccin
strain
addit
need
test
pathogen
pregnant
cow
grow
fetu
stress
thu
demand
studi
pathogenesi
fetal
bvdv
infect
effect
bvdv
infect
fetal
develop
repeat
kahr
although
mcclurkin
et
al
report
kill
bvdv
vaccin
may
safe
pregnant
cattl
also
produc
adequ
antibodi
protect
fetu
intrauterin
infect
live
attenu
bvdv
vaccin
continu
manufactur
larg
scale
use
wide
stimul
field
studi
transmiss
possibl
fetopathogen
effect
bvdv
administr
commerci
live
viru
vaccin
dam
first
half
gestat
commenc
gestat
day
vaccin
appli
seroneg
pregnant
cattl
herd
less
anim
neutral
antibodi
five
abort
occur
day
vaccin
bvdv
infect
confirm
one
three
case
submit
laboratori
five
calv
torticolli
opisthotonu
ataxia
astasia
born
term
dam
vaccin
day
gestat
nine
calv
precolostr
viremia
persist
anim
sold
sacrif
chronic
diseas
fig
one
calf
becam
year
old
show
growth
retard
appear
otherwis
normal
calv
born
persist
viremia
usual
precolostr
antibodi
except
three
low
titer
demonstr
hazard
caus
vaccin
properli
test
decid
whether
vaccin
viru
bvd
field
viru
pick
caus
effect
bovin
cell
cultur
use
propag
vaccin
viru
need
proper
pretest
order
rule
dissemin
bvd
field
viru
vaccin
control
bvd
use
live
attenu
vaccin
calv
requir
determin
suscept
age
vaccin
colostr
immun
interfer
immun
accord
kahr
et
al
immun
last
month
correl
presenc
matern
deriv
neutral
antibodi
robson
et
al
rate
antibodi
declin
similar
calv
vaccin
natur
immun
dam
calcul
halflif
day
landeliu
shorter
durat
result
lower
initi
titer
kahr
et
al
due
use
antigen
differ
strain
bvdv
shown
fig
sinc
frequent
revaccin
feasibl
one
two
vaccin
might
assur
success
immun
greatest
number
calv
earliest
possibl
age
earli
possibl
bvd
field
infect
becam
visibl
group
calv
fig
develop
activ
immun
titer
antibodi
still
high
lackmannpavenstedt
sinc
usual
bvdv
enter
bovin
organ
oronas
rout
even
high
antibodi
titer
blood
prevent
infect
result
activ
immun
liess
et
al
littl
known
local
immun
bvd
must
expect
play
import
role
protect
therefor
live
bvdv
vaccin
probabl
appli
local
exampl
intranas
instil
although
report
pertin
studi
avail
rememb
intranas
rout
use
success
challeng
bvdv
sever
investig
immun
neutral
antibodi
effici
induc
veterinari
control
measur
reli
diagnost
tool
detect
persist
infect
cattl
vaccin
use
safe
vaccin
question
persist
bvdv
infect
anim
elimin
herd
applic
live
viru
vaccin
seroneg
group
consid
variou
aspect
vaccin
appli
well
breed
age
prior
situat
involv
high
risk
exposur
howev
vaccin
becom
gambl
soon
antibodi
preval
within
parent
popul
approach
also
newborn
calv
would
receiv
matern
antibodi
immun
failur
would
result
earli
vaccin
late
vaccin
would
retain
suscept
earli
calfhood
kahr
et
al
control
measur
depend
manag
condit
may
adapt
accordingli
malmquist
kahr
lymphoid
tissu
acta
vet
scand
